1. Home
  2. MRVI vs CTKB Comparison

MRVI vs CTKB Comparison

Compare MRVI & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • CTKB
  • Stock Information
  • Founded
  • MRVI 2020
  • CTKB 1990
  • Country
  • MRVI United States
  • CTKB United States
  • Employees
  • MRVI N/A
  • CTKB N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MRVI Health Care
  • CTKB Health Care
  • Exchange
  • MRVI Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • MRVI 795.7M
  • CTKB 718.8M
  • IPO Year
  • MRVI 2020
  • CTKB 2021
  • Fundamental
  • Price
  • MRVI $4.11
  • CTKB $5.12
  • Analyst Decision
  • MRVI Buy
  • CTKB Strong Buy
  • Analyst Count
  • MRVI 10
  • CTKB 2
  • Target Price
  • MRVI $10.28
  • CTKB $9.25
  • AVG Volume (30 Days)
  • MRVI 2.4M
  • CTKB 760.6K
  • Earning Date
  • MRVI 02-25-2025
  • CTKB 02-27-2025
  • Dividend Yield
  • MRVI N/A
  • CTKB N/A
  • EPS Growth
  • MRVI N/A
  • CTKB N/A
  • EPS
  • MRVI N/A
  • CTKB N/A
  • Revenue
  • MRVI $276,920,000.00
  • CTKB $201,210,000.00
  • Revenue This Year
  • MRVI N/A
  • CTKB $7.26
  • Revenue Next Year
  • MRVI $1.93
  • CTKB $8.20
  • P/E Ratio
  • MRVI N/A
  • CTKB N/A
  • Revenue Growth
  • MRVI N/A
  • CTKB 9.88
  • 52 Week Low
  • MRVI $3.93
  • CTKB $4.66
  • 52 Week High
  • MRVI $11.56
  • CTKB $9.33
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 35.37
  • CTKB 37.48
  • Support Level
  • MRVI $4.05
  • CTKB $5.18
  • Resistance Level
  • MRVI $4.40
  • CTKB $5.48
  • Average True Range (ATR)
  • MRVI 0.31
  • CTKB 0.27
  • MACD
  • MRVI -0.05
  • CTKB 0.01
  • Stochastic Oscillator
  • MRVI 15.38
  • CTKB 27.85

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: